AmVaz decision could block biogenerics
Earlier this week, the US Food and Drug Administration suspended the approval of a generic version of Pfizer's high blood pressure drug Norvasc (amlodipine besylate) developed by India's Dr Reddy's Laboratories. The case could have significant...